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Summary.-Mononuclear cell fractions were isolated from blood, ascites and solid
tumours of patients undergoing surgery for Stages III and IV adenocarcinoma of
the ovary, and evaluated for their response in NK, ADCC and PHA assays. Control
experiments with the same fraction of normal blood indicated that these responses
were not influenced by the enzymes used to isolate the tumour and ascites inflamma-
tory cells. The inflammatory cell fractions isolated from both tumour sites which
sedimented in the velocity range ofblood mononuclear cells were adequate in number
and composition for comparison with similar cells from blood. E RFC values in both
ascites and tumour fractions exceeded those of patient blood. However, there was
a marked difference in distribution of the T subsets between blood, ascites and
tumour, which could cause the variable test results between the different cell sources.
PHA responses ofpatient blood and ascites fractions were about halfthat ofnormal
blood. Tumour-infiltrating lymphocytes (TIL) were less than 10% as responsive
as normal blood. The depressed PHA responses of the TIL were not due to the
presence of a suppressor cell population. NK activity of patient blood was less than
that of normal blood, but not as much as the ascites or TIL cells. The activity of
the ascites-derived lymphocytes was enhanced by treatment with interferon. ADCC
activity against both CRBC and SB cells was normal or higher than controls in
patient blood, and depressed in the ascites-derived fractions. TIL responded to
<10% of the patient blood values.
The results indicate a lack of response by ascitic and TIL cells in assays dependent
onFcR-bearing effectorcells and a greaterloss ofPHA-reactive cellsfromthetumour
than from blood and ascites. These data could result from intratumour inactivation,
or a failure of the particular subset to localize either In the ascites or the tumour
site.
SUCCESSFUL monitoring of antitumour
immunity depends on a knowledge of
both systemic and intratumour immuno-
logical events. Because blood represents
essentially the sole source by which
immune competence can be followed, it is
important to determine whether activity
in patient peripheral-blood leucocytes is
representative of what is actually taking
place in the tumour. There have been
numerous reported investigations of the
tumour- and ascites-isolated macrophages
and lymphocytes from both animals
(Russell et al., 1980; Herbermann et al.,
1980; Haskill et al., 1979, 1978) and
humans (Mantovani et al., 1979; Klein
et al., 1980; Werkmeister et al., 1979;
Vose & Moore, 1979; Totterman et al.,
1980) with various results in animals, but
most of the clinical studies have failed
to detect intratumour activity. In addi-
tion, many of these studies have notS. HASKILL, H. KOREN, S. BECKER, W. FOWLER AND L. WALTON
focused on a particular cancer type,
making the results more difficult to
compare.
We have initiated a study of the
immune competence of the inflammatory
cell types infiltrating solid and ascitic
ovarian tumours derived from patients
prior to therapy. In the accompanying
paper (Haskill et al., 1982) we outline the
methods of isolating these cells, and their
cell markers. Two classes were character-
ized: those sedimenting less than 6mm/h
and similar in size to most of the blood
cells and a series of larger macrophages
cytochemically distinct from blood mono-
cytes, which sediment with tumour cells.
The present report documents the
activity of the blood-like cells, in both
patient and normal blood mononuclear
cell fractions. The data indicate a general
lack of functional NK, ADCC and PHA
response, with the exception of ascitic
inflammatory cells, where mitogenic ac-
tivity resembles that in autologous blood.
MATERIALS AND METHODS
Humansubjects-Thirty-eight patients with
histologically confirmed epithelial cancer of
the ovary were used in this study. All but
one were classified as Stages III or IV.
Most patients provided both ascites and
solid-tumour material for analysis. In several
cases, both ovarian and omental tumour
sites were obtained. Because surgical removal
of the ovary left only the extensive omental
tumour to be treated, when available, this
tissue was used for analysis, as it represented
the target forfurthertherapy.
Heparinized venous blood was collected
from patients at surgery, when available.
Healthy laboratory workers supplied control
blood.
Enzymatic digestion of the tumours and
sedimentation-velocityseparation.-Thegeneral
methodologies have been extensively de-
scribed in Haskill et al., 1982.
Mitogen response.-A series of preliminary
investigations was carried out in order to
determine the optimal conditions for study-
ing mitogen response with relatively low
cell numbers (5 x 103-2 x 104 per well).
Both ascites and tumour-derived lympho-
cyte (TIL) responses were investigated with
regard to the requirement for human serum,
concentration of PHA, type of culture
vessel, duration of assay and cell viability.
We were unable to find marked differences
between the various cell sources. Therefore
the following conditions were routinely used:
5x 103, 104 and 2 x 104 cells were cultured
in U-bottomed 96-well microtest plates
(Linbro-MRC-9TC). The medium consisted
of 10% FCS in RPMI 1640 (Grand Island
Biological Co.). PHA (Wellcome Research
Laboratories, Beckenham) was added to a
final concentration of 1 ,g/ml. Cells were
cultured for 4 days with or without mitogen
at each cell concentration. [3H]dT (New
England Nuclear, Boston, Mass.) was added
to a final concentration of 5 0Ci/ml. Cells
were harvested 4 h later. Data are presented
as total specific ct/min incorporated, because
stimulation indices tended to hide the poor
response of the TILs. Specific ct/min in-
corporated=ct/min (PHA) -ct/min (control).
Cr-labelling of target cells.-From 10 to
20 x 106 cells were resuspended in 0-2 ml
of MEM-10%. One hundred uCi of Na2
51CrO4 (sp. act. 250-500 mCi/mg of 51Cr,
New England Nuclear, Boston, Mass., Cat.
No. NEZ-030) at a concentration of 100
/Ci/501A was added to the target cells, which
were then incubated in a 37 0C water bath
for 1 h with occasional shaking. Labelled
target cells were washed x 3 with MEM-10%
and adjusted to the desired concentration.
Assay for NK activity.-Effector cells
were tested against 51Cr-labelled K562
targets. Triplicate determinations were made
in U-bottomed microtitre plates (Linbro,
Is-MRC-96TC) in a total volume of 0-2 ml.
Effector cells were tested in every experiment
at 3 concentrations, against a constant dose
of target cells, producing 20:1, 10:1 and
5: 1 E:T ratios. Results presented in this
paper include only one E:T ratio. Thetumour
targets were added at 104 cells/well. The
plates were centrifuged for 3 min at 80 g to
facilitate cell contact, and then incubated for
an additional 2 h at 37°C in a humidified
7% CO2 incubator. The assay was terminated
by centrifuging the plates for 5 min at 500 g,
and subsequently harvesting 0-1 ml of the
supernatant.
Assay for ADCC activity.-Both SB and
CRC targets were modified with trinitro-
benzene sulphonic acid, as previously de-
scribed (Snyderman et al., 1977). The hap-
tenated cells will be referred to as SB-TNP
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and CRC-TNP. A portion of the modified
cells (51Cr-labelled SB-TNP and cold SB-
TNP and CRC-TNP) were then adjusted to
106 cells/ml and incubated with rabbit
hyperimmune anti-TNP serum for 30 min
at 37°C. SB-TNP targets were coated with a
1:480 final dilution of anti-TNP serum in
MEM-10%, whereas the CRC-TNP targets
were coated in a 1:2400 dilution to avoid
agglutination of these targets. Anti-TNP-
coated target cells, designated SB-TNP-anti-
TNP and CRC-TNP-anti-TNP, were then
washed x 3 to remove excess anti-TNP
serum from the medium, and adjusted to
the desired concentration. As in the case
of NK assays, effector cells were tested at 3
concentrations against a 104 51Cr-labelled
SB-TNP-anti-TNP, but results from only
one E:T ratio are presented. The subsequent
steps of the assay were identical to those
ofthe NK assays.
Calculation of cytoxicity.-For both the
NK and ADCC assays, spontaneous release
(SR) was defined as ct/min released from
targets incubated with medium alone. Max-
imal release (MR) was determined by
measuring ct/min in the supernatants after
detergent lysis (1% Triton x 100) of the
various target cells. The formula used to
calculate the percent specific release was:
ct/min (experimental) -ct/min (spontaneous)
ct/min (maximal) -ct/min (spontaneous)
Datawerecalculatedandstatisticallyanalysed
by a program using the above formula, with a
PDP 11/20 computer (Digital Equipment
Corp., Maynard, Mass.).
Treatment with interferon (IFN).-Cells (2 x
106/ml) were incubated with 100 u/ml of
IFN (partially purified human IFN, Hem
Research kindly provided by Dr J. Ortaldo)
for 18 h in 12-75 mm tubes at 37°C. The
cells were then washed twice with MEM-10%
and then assayed for cytotoxicity.
RESULTS
Mitogen response
The methods used are summarized in
Fig. 4.
Although 3 different concentrations of
lymphocytes were used in each experi-
ment, to simplify the presentation, only
the results obtained at 104 cells/well are
given. Because similar dose-response rela-
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Fia. 1.-PHA responses of peripheral.
blood mononuclear cells derived from
normal donors (NB) and from ovarian-
cancer patients (PB) at time of surgery.
Tumour (TuL) and ascites (AscL) mono-
nuclear cell fractions were obtained by
sedimentation-velocity separation (Haskill
et al., 1982). The mean E RFC values for
each cell source are given in Fig. 4. Re-
sponses were determined at 3 cell concen-
trations, but as the responses were similar,
only tlle intermediate concentration
(104/well) is shown. Bars represent the
mean of each group.
tionships were noted in each case, the
interpretation was the same for all cell
numbers used.
Fig. 1 summarizes our results in a
study of 18 patients. Patient blood
responded about half as well as control
healthy donors (13.6 vs 23-0 x 103 ct/min.
In contrast, few of the TILs responded
significantly to PHA (1.7 x 103 ct/min).
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TABLE I.-Frequencyoftumour andascitesmononuclear-cellresponses >50%
of autologous blood*
PHA NK
Ascites Tumour Ascites Tumour
11/14 1/13 6/12 2/11
* Data from Figs 1 & 3.
ADCC(SB)
Ascites Tumour
6/12 1/9
ADCC(CRC)
Ascites Tumour
3/8 0/8
Fig. 1 describes all the blood, ascites
and tumour-associated responses as popu-
lation distributions. When data were
analysed on an individual basis (i.e.
tumour and ascitic responses compared
to autologous blood) 11/14 ascites fractions
responded with values at least 50% of
the autologous blood response, but only
1/13 tumour fractions responded as well
(Table I).
Variation in assay conditions
Because the optimal conditions for
TIL responses need not be the same as
those of normal blood, a series of experi-
ments was carried out to identify possible
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FIG. 2.-Investigation of the possible
suppressive influence of tumour-derived
lymphocytes (TIL) on autologous blood
mononuclear-cell PHA responses. Some
of the fractions used in Fig. 1 were
cultured alone (Bloods or TIL .) or
mixed in equal portions with autologous
blood cells (DO). In the 7 experiments
(from 7 patients) no suppression was seen.
104 cells per culture well alone; 2 x 104 in
the mixtures.
variables in this assay, such as the use
ofpooled human AB or autologous serum
rather than FCS, length ofassay, viability
of cultured cells and optimal PHA
concentration. As significant differences
were not found with any of these factors,
assay conditions were maintained as
for blood responses.
Presence of suppressor cells within tumour-
infiltrating cells
Depressed responses could have been
the result of isolating a suppressor
population with the other inflammatory
cells. A series of experiments was carried
out to investigate this possibility, in
which TILs were mixed in various
proportions with autologous b loodmono-
nuclear cells. The TILs failed to sup-
press the PHA response in 7 tests out
of 7. The data from mixing experiments
with equal numbers of patient blood and
infiltrating cells is shown in Fig. 2. The
results indicated that the sums of the
individual responses were similar to the
responses of the mixtures. Only with
samples SF and MF was there an indica-
tion of enhanced response.
Natural killer cell (NK) activity
NK activity was assessed with the
K562 cell as target, using the same
effector cell populations as described
above for PHA responses. The results
of these assays indicated a considerable
spread in activity between both normal
and patient blood values. However, it
was clear that both ascites and TIL cells
responded poorly, with little overlap
between blood and tumour values (Fig. 3).
Although the overall response of these
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FIG. 3.-NK and ADCC activity ofperipheral-
blood mononuclear cells derived from nor-
mal donors and ovarian-cancer patients.
Fractions and Symbols are as in Fig. 1.
NK activity against the K562 target cell,
and ADCC activity against the tumour-
cell target (SB) or erythrocyte target (CRC)
were determined at 3 ratios, but only the
data for one of these is given (E:T = 20: 1
for NK and ADCC (SB) and 3: 1 for
ADCC (CRC)). The bars represent the
means.
cells was low, 6/12 ascites values were
>50% of the autologous blood values
(Table I), suggesting that at least part
of the lack of response of ascites-derived
lymphocytes may have been a more
general phenomenon than afunction of the
ascites environment. Only 2/11 TIL
samples responded >50% of autologous
blood (Table I).
ADCC activity
Two different target cells were used
to assess the ADCC competence of blood,
ascites and TIL cells. The CRC assay
detects both macrophage and K-cell
killing (Lovchik & Hong, 1977) whilst
the SB tumour targets are killed prim-
arily by K cells (Lovehik & Hong, 1977)
and activated macrophages (Koren et al.,
1981). Activity against both the CRC
and SB target cells was at least as high
in patient blood as normal blood. Both
the ascites and tumour-associated sites
provided effector cells of low specific
activity against both the SB and CRC
targets. Only on 1/9 occasions did the
response of the TILs exceed 50% of
autologous blood (SB target) (Table I).
Effect of collagenase treatment on cell
markers andfunction
Collagenase is a relatively gentle proteo-
lytic enzyme, and thus often used for
tumour disaggregation. It has been shown
that membrane glycoproteins, T- and
B-cell markers and Fc receptors are not
affected by short-term treatment with
collagenase (Hayry & Totterman, 1978).
We also studied the potential that
collagenase might have for influencing
the various cellular effector activities
studied herein. Collagenase treatment of
normal blood lymphocytes for 20 min
under the same conditions as in tumour
disaggregation did not affect activity
(Table II), nordidit changesedimentation-
velocity distribution patterns (data not
shown).
Association of cell markers with effector-cell
activity
As lack of effector-cell activity could
arise from an absence of the lymphocyte
subset from the tumour site, it was of
TABLE II.-Effect ofcollagenase on various cellular effector mechanisms
PHA*
(ct/min)
Control 95850
Collagenase 111655
NKt
(% release)
55-2
53-5
ADCCt
(% release)
SB CRC
52-4 28-0
51-0 25-9
* 2 x 104 cells per assay; mean of 4 wells.
t E :T= 20:1, Mean of 4 wells.
$ SB; E:T=20:1, CRC; E:T=3:1. Mean of3 wells. Results
were similar at all 3 E :T ratios tested.
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interest to compare the proportions of
eacheffectorcell(cytochemicallyidentified)
with the relevant level of activity in
that site. Effector cells associated with
PHA response, NK and ADCC activity
are characterized by a series of distinct
cytochemical markers. The T-cell subset
(recognized by formation of a stable
E RFC) which shows a characteristic
large dot of ANAE staining is associated
with PHA responsiveness (Moretta et al.,
1978). NK cells are known to belong to
another T-cell subset which is character-
ized by a lack of ANAE staining and a
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FIG. 4.-Summary of immunocytoche
data obtained on cell fractions us
Figs 1 & 3. (Data from Haskill t
1982). ANAE+E RFC values
determined on cytocentrifuge prepara
and are given as a % total E RFC i
than total cells. FcR+ cells were
mined using the EA RFC assay.
specific esterase (NSE) values rep]
only the monocyte component of
fraction.
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FIG. 5.-Summary of PHA, NK, and ADCC
activities in Fig 1 & 3. The mean values
are given for comparison with the immuno-
cytochemical marker data (Fig. 4).
distinct granular staining with Giemsa.
They are referred to as large granular
lymphocytes (LGL) (Saksela et al., 1979a).
Fc R+ ADCC activity against the SB target
cell is associated with FcR-bearing E RFC
cells, including cells of the NK class of
lymphocytes (Kall & Koren, 1978). ADCC
activity against the CRBC target is due
to cells of the monocyte (FcR+ and
NSE+) lineage as well as K cells (Lovehik
N S E + & Hong, 1977).
The summarized data relating to the
various effector-cellassaysandtherelevant
cytochemical markers are given in Figs
4 and 5 respectively.
PHA responsiveness.-The pattern of
Emical ANAE+ T cells in the different test
etea.n populations (Fig. 4) is similar to the PHA
were responsiveness of the various effector-
ttions, cell sources (Fig. 5) suggesting that
rather
ac deter- activity depends upon the presence of
Non- that cell class.
resent NK responsiveneS8s.-Although E RFC+
each cells characteristic of the NK class
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TABLE III.-% LGL
Normal blood 16*2+1 6
Patient blood 27 *0+5*7
Ascites 5O0+2-0
* Large granular lymphocytes; iden-
tified by the procedure ofSaksela et al.
(1979); 6 samples in each group. Only
E RFC+ cells were scored.
(LGL) were present in the patient blood
(Table III) they were not active. Because
ofthe low activity in blood in the presence
of the marker, the absence of both
activity and the LGL marker from
the ascites fraction need not be related.
Although several experiments were con-
ducted to investigate the presence of
suppressor cells of the NK activity, we
were unable to detect them.
ADCC: SB target-cell assay.-Although
there is generally a close association in
properties between NK cells and ADCC
effector cells to this target, it seems
probable that the high activity in patient
blood in contrast to NK activity, repre-
sents another example of the dissociation
ofthese two activities (Koren et al., 1978).
ADC: CaRBO target-cell assay.-As
monocytes are known to participate in
the lysis of this target cell (Lovehik &
Hong, 1977) it was anticipated that the
level of NSE+ cells of monocytic mor-
phology would give a representation of
this effector cell. The data indicate,
however, that there is little relationship
between mean ADCC values and average
levels of monocytes in the TIL fraction.
This would appear to indicate that cells
morphologically characteristic of effector
cells in this assay are present but inactive.
Effect of ascites fluid on blood-lymphocyte
reactivity
Effector-cell activity (NK, ADCC) as-
sociated with FcR+ cells from ovarian
ascites is generally very depressed. How-
ever, ascites fluids are known to contain
immunosuppressive factors (Hess et al.,
1979) as well as immune complexes
(Poulton et al., 1978). Several attempts
were made to influence activity in each
assay by incubating normal blood mono-
nuclear cells overnight with 18 different
ascitic fluids, associated with either the
most depressed or most active of values
for ascitic NK activities. None of the
fluids influenced PHA activity, whilst
3/18 depressed NK activity by <30%
(data not shown).
Effect of interferon on blood and ascites
lymphocyte reaction to K562C
Several reports have indicated that
interferon (IFN) can enhance NK activity,
either through stimulation of pre-NK
cells (Saksela et al., 1979b) or stimulation
of endogenous NK activity (Zarling et al.,
1980). A similar study to the present one
(Mantovani et al., 1980) indicates that
depressed levels of ascites NK activity
can be stimulated by IFN. Our results
confirm this observation and suggest that
enhancement of cytotoxicity occurs after
overnight incubation of ascites lympho-
cytes with IFN (Table IV). Although
the mean augmentation of activity was
TABLE IV.-% Specific isotope release (+/ - IFN)*
Expt
1
2
3
4
5
6
Mean
Mean % augmentation
* E:T = 20: 1.
Normal Asc. lymph
55/52 15/10
16/5 9/2
65/59 22/16
74/60 21/8
33/16 9/6
76/49 47/20
53-2+ 10-1/40-2+ 10-6 20-5+6-3/10.3+3-0
35 100
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100%, compared to the control value of
35%, the level of activity was still only
39% of the control level (20.5 vs 53.2).
DISCUSSION
Mononuclear-cell infiltration of cancer
is generally thought to be related to
better survival (Underwood, 1974; Ioa-
chim, 1976). In an attempt to delineate
the role played by various effector
mechanisms in situ, numerous studies
have been reported in which tumour
infiltrating cells have been isolated from
highly immunogenic animals tumours
(Russell et al., 1980; Herberman et al.,
1980; Haskill et al., 1979, 1978) as well
as from human tumours (Mantovani
et al., 1979; Klein et al., 1980; Werk-
meister et al., 1979; Totterman et al., 1980;
Vose & Moore, 1979). Several studies
have investigated the in vitro activity of
TILs from human tumours but none have
attempted to find an association between
effector-cell presence and survival. Al-
though it is the hope oftumour immunolo-
gists that recognition and infiltration of
cancer is immune in nature, infiltration
of an inflammatory site may be non-
specific (Koster et al., 1971). Therefore, a
tumourundergoing necrotic changes, blood
vessel development and destruction could
well contain cells attracted through a
variety of non-specific mechanisms.
Systemic and in situ immunity need
not be directly comparable (Haskill et al.,
1978). While very little is known about
restrictions on lymphocyte localization
in tumours, several studies suggest that
the distribution of these cells varies with
the anatomic and perhaps the inflam-
matory site. Lymphocytes infiltrating
sites of inflammation are likely to be
long-lived (Mule et al., 1979), The propor-
tions of ANAE+ T cells are markedly
different in blood and lymph nodes
(Moretta et al., 1978). Lymphocytes iso-
lated from normal lung washings of both
humans (Daniele et al., 1975) and dogs
(Ansfield et al., 1979) are poorly responsive
to mitogens. In both cases, the depressed
responses were inherent properties of the
lymphocytes rather than a result of
suppressor macrophages. Thus, it is not
surprising that systemic and in situ
immunityneednotbedirectly comparable.
In the present paper we have investi-
gated the activity of ascites and TIL
cells in the PHA, NK, and ADCC assays.
The results clearly indicate that tumour-
derived inflammatory cells of the same
size as blood mononuclear cells are
unresponsive in all the tests applied.
Total T cells, FcR+ and NSE+ cells
were similar to those in blood, yet
functionalactivitywasabsent.TheANAE+
T-cell subset, however, was markedly
diminished in tumour tissue, suggesting
that low PHA response could be a
result of lack of recruitment of this class
in situ.
PHA unresponsiveness of TILs may
be tumour-type dependent. Whereas cells
isolated from breast tumour failed to
respond to PHA (Blomgren et al., 1973),
Klein et al. (1980) using a similar method-
ology to ours, routinely detect PHA
responses with TIL from different classes
of tumour. Recently, Vose & Moore
(1979) have examined this in more detail,
and have reported that TIL may be
hyporesponsive to PHA, but are usually
suppressive of the autologous blood re-
sponse. We have not been able to demon-
strate suppressor-cell activity in the TIL
fraction.
Totterman et al. (1980) have investi-
gated both NK and autologous cytotoxic
activity in infiltrating cells isolated from
a series of human tumour biopsies.
They failed to find significant activity,
even though patient blood was frequently
responsive. Immunocytochemical analysis
of the cell types present suggested that
lack of NK activity could be ascribed
to a marked depletion ofNK cells (Saksela
et al., 1979a).
Vose et al. in 1977 (reviewed in Klein
et al., 1980) carried out a more extensive
and detailed investigation ofTIL function
in a wide spectrum of cancer types,
including nasopharyngeal carcinoma, var-
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ious primary and secondary lung tumours
and sarcomas. Their data indicate a
number of valuable points. First, tumour
type may play an important role in the
results obtained. Lymphocytes from only
2/12 lung tumours were cytolytic against
autologous target cells, whereas 9/18
othercarcinomasandsarcomashaddemon-
strable activity. NK activity was absent
from all but 1/41 preparations of TIL.
Mantovani et al. (1980) have recently
reported anextensive series ofexperiments
using ovarian ascites lymphoid cells in
the NK assay. They observed activity
in blood and ascites, though blood was
usually the higher and both were sig-
nificantly below control blood values.
The two normal PC populations showed
very little activity. Our results indicated
a similar depression of patient blood
activity, but a greater drop in NK
activity, when ascites lymphoid cells
were used. There are several possibilities
for this discrepancy. Mantovani et al.
(1980) used a 20h assay, whereas we
used a 4h assay; however, they have
data suggesting that this may be un-
important. Our ascites lymphocyte frac-
tion averaged 77% E RFC whereas those
used by Mantovani et al. (1980) averaged
39% E RFC. Levels of FcR+ cells
were similar. As the values for blood
E RFC are within the expected values,
the twofold differences in T-cell levels
must be related either to the separation
procedures or to the patient population.
Our separation method used only one
step in isolating a mononuclear-cell frac-
tion from tumour or ascites preparations.
In the studies of Mantovani et al. (1980)
several approaches were used, both of
which involved, step-wise, enrichment
procedures which may have produced
depletion of particular segments of the
various lymphocyte and monocyte popu-
lations.
In summary, these data indicate that
TILs in ovarian cancer are in general
low in activity in our 4 tests, whereas
ascites preparations were more variable
in degree of response. It is concluded
that several factors, including immuno-
suppression due to cancer, and selective
immigration, may account for the low
activity associated with many patients.
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